nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinastine—ADRA2A—type 2 diabetes mellitus	0.248	0.685	CbGaD
Epinastine—CYP3A4—type 2 diabetes mellitus	0.114	0.315	CbGaD
Epinastine—HTR7—Bromocriptine—type 2 diabetes mellitus	0.0764	0.17	CbGbCtD
Epinastine—HTR2A—Bromocriptine—type 2 diabetes mellitus	0.0351	0.0782	CbGbCtD
Epinastine—ADRA2A—Bromocriptine—type 2 diabetes mellitus	0.0351	0.0782	CbGbCtD
Epinastine—ADRA1A—Bromocriptine—type 2 diabetes mellitus	0.0337	0.0749	CbGbCtD
Epinastine—ABCB1—Linagliptin—type 2 diabetes mellitus	0.028	0.0623	CbGbCtD
Epinastine—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0249	0.0555	CbGbCtD
Epinastine—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.018	0.0401	CbGbCtD
Epinastine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.017	0.0378	CbGbCtD
Epinastine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0168	0.0373	CbGbCtD
Epinastine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0157	0.0349	CbGbCtD
Epinastine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0149	0.0333	CbGbCtD
Epinastine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0137	0.0304	CbGbCtD
Epinastine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0129	0.0287	CbGbCtD
Epinastine—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0124	0.0276	CbGbCtD
Epinastine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0123	0.0275	CbGbCtD
Epinastine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0119	0.0266	CbGbCtD
Epinastine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0108	0.0241	CbGbCtD
Epinastine—ABCB1—Glyburide—type 2 diabetes mellitus	0.00923	0.0206	CbGbCtD
Epinastine—ABCB1—Losartan—type 2 diabetes mellitus	0.00844	0.0188	CbGbCtD
Epinastine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00819	0.0182	CbGbCtD
Epinastine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00785	0.0175	CbGbCtD
Epinastine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00785	0.0175	CbGbCtD
Epinastine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00742	0.0165	CbGbCtD
Epinastine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00553	0.0123	CbGbCtD
Epinastine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00506	0.0113	CbGbCtD
Epinastine—HTR7—sympathetic nervous system—type 2 diabetes mellitus	0.00384	0.1	CbGeAlD
Epinastine—HTR2A—arteriole—type 2 diabetes mellitus	0.00376	0.098	CbGeAlD
Epinastine—HTR7—autonomic nervous system—type 2 diabetes mellitus	0.00258	0.0673	CbGeAlD
Epinastine—HTR2A—sympathetic nervous system—type 2 diabetes mellitus	0.0024	0.0625	CbGeAlD
Epinastine—HTR7—peripheral nervous system—type 2 diabetes mellitus	0.00186	0.0486	CbGeAlD
Epinastine—Nasopharyngitis—Linagliptin—type 2 diabetes mellitus	0.00181	0.0286	CcSEcCtD
Epinastine—Upper respiratory tract infection—Linagliptin—type 2 diabetes mellitus	0.00162	0.0257	CcSEcCtD
Epinastine—HTR2A—autonomic nervous system—type 2 diabetes mellitus	0.00161	0.042	CbGeAlD
Epinastine—Upper respiratory tract infection—Nateglinide—type 2 diabetes mellitus	0.00152	0.0241	CcSEcCtD
Epinastine—HTR2A—hindlimb—type 2 diabetes mellitus	0.00149	0.0388	CbGeAlD
Epinastine—HTR7—artery—type 2 diabetes mellitus	0.00146	0.0382	CbGeAlD
Epinastine—HTR7—nerve—type 2 diabetes mellitus	0.00145	0.0379	CbGeAlD
Epinastine—Nasopharyngitis—Rosiglitazone—type 2 diabetes mellitus	0.00138	0.0219	CcSEcCtD
Epinastine—ADRA2A—peripheral nervous system—type 2 diabetes mellitus	0.00137	0.0356	CbGeAlD
Epinastine—Upper respiratory tract infection—Rosiglitazone—type 2 diabetes mellitus	0.00124	0.0197	CcSEcCtD
Epinastine—HTR7—endothelium—type 2 diabetes mellitus	0.00124	0.0323	CbGeAlD
Epinastine—Sinusitis—Repaglinide—type 2 diabetes mellitus	0.00118	0.0188	CcSEcCtD
Epinastine—HTR2A—peripheral nervous system—type 2 diabetes mellitus	0.00116	0.0303	CbGeAlD
Epinastine—Rhinitis—Repaglinide—type 2 diabetes mellitus	0.00113	0.018	CcSEcCtD
Epinastine—Nasopharyngitis—Sitagliptin—type 2 diabetes mellitus	0.00113	0.0179	CcSEcCtD
Epinastine—Sinusitis—Rosiglitazone—type 2 diabetes mellitus	0.00112	0.0177	CcSEcCtD
Epinastine—Cough—Linagliptin—type 2 diabetes mellitus	0.00106	0.0168	CcSEcCtD
Epinastine—Upper respiratory tract infection—Pioglitazone—type 2 diabetes mellitus	0.00104	0.0165	CcSEcCtD
Epinastine—Nasopharyngitis—Bromocriptine—type 2 diabetes mellitus	0.00102	0.0162	CcSEcCtD
Epinastine—Upper respiratory tract infection—Sitagliptin—type 2 diabetes mellitus	0.00101	0.016	CcSEcCtD
Epinastine—HRH2—cardiovascular system—type 2 diabetes mellitus	0.001	0.0261	CbGeAlD
Epinastine—Cough—Nateglinide—type 2 diabetes mellitus	0.000993	0.0158	CcSEcCtD
Epinastine—Infection—Linagliptin—type 2 diabetes mellitus	0.000986	0.0156	CcSEcCtD
Epinastine—Rhinitis—Glipizide—type 2 diabetes mellitus	0.000938	0.0149	CcSEcCtD
Epinastine—Sinusitis—Pioglitazone—type 2 diabetes mellitus	0.000937	0.0149	CcSEcCtD
Epinastine—Pharyngitis—Glipizide—type 2 diabetes mellitus	0.000929	0.0147	CcSEcCtD
Epinastine—HTR2A—artery—type 2 diabetes mellitus	0.000913	0.0238	CbGeAlD
Epinastine—Sinusitis—Sitagliptin—type 2 diabetes mellitus	0.00091	0.0144	CcSEcCtD
Epinastine—HTR2A—nerve—type 2 diabetes mellitus	0.000906	0.0236	CbGeAlD
Epinastine—Cough increased—Ramipril—type 2 diabetes mellitus	0.000897	0.0142	CcSEcCtD
Epinastine—Pharyngitis—Pioglitazone—type 2 diabetes mellitus	0.00089	0.0141	CcSEcCtD
Epinastine—Pharyngitis—Sitagliptin—type 2 diabetes mellitus	0.000864	0.0137	CcSEcCtD
Epinastine—Sinusitis—Bromocriptine—type 2 diabetes mellitus	0.000824	0.0131	CcSEcCtD
Epinastine—Rhinitis—Bromocriptine—type 2 diabetes mellitus	0.00079	0.0125	CcSEcCtD
Epinastine—Pruritus—Tolbutamide—type 2 diabetes mellitus	0.00078	0.0124	CcSEcCtD
Epinastine—HTR2A—endothelium—type 2 diabetes mellitus	0.000771	0.0201	CbGeAlD
Epinastine—Infection—Rosiglitazone—type 2 diabetes mellitus	0.000755	0.012	CcSEcCtD
Epinastine—Upper respiratory tract infection—Gliclazide—type 2 diabetes mellitus	0.000751	0.0119	CcSEcCtD
Epinastine—Pruritus—Chlorpropamide—type 2 diabetes mellitus	0.000709	0.0113	CcSEcCtD
Epinastine—Pruritus—Tolazamide—type 2 diabetes mellitus	0.000709	0.0113	CcSEcCtD
Epinastine—Nasopharyngitis—Metformin—type 2 diabetes mellitus	0.0007	0.0111	CcSEcCtD
Epinastine—Headache—Tolbutamide—type 2 diabetes mellitus	0.00069	0.011	CcSEcCtD
Epinastine—Upper respiratory tract infection—Valsartan—type 2 diabetes mellitus	0.00069	0.0109	CcSEcCtD
Epinastine—Upper respiratory tract infection—Orlistat—type 2 diabetes mellitus	0.000682	0.0108	CcSEcCtD
Epinastine—Sinusitis—Gliclazide—type 2 diabetes mellitus	0.000676	0.0107	CcSEcCtD
Epinastine—Cough—Sitagliptin—type 2 diabetes mellitus	0.000661	0.0105	CcSEcCtD
Epinastine—Nasopharyngitis—Irbesartan—type 2 diabetes mellitus	0.00066	0.0105	CcSEcCtD
Epinastine—Pruritus—Nateglinide—type 2 diabetes mellitus	0.000657	0.0104	CcSEcCtD
Epinastine—Rhinitis—Gliclazide—type 2 diabetes mellitus	0.000649	0.0103	CcSEcCtD
Epinastine—Pharyngitis—Gliclazide—type 2 diabetes mellitus	0.000642	0.0102	CcSEcCtD
Epinastine—Infection—Pioglitazone—type 2 diabetes mellitus	0.000633	0.01	CcSEcCtD
Epinastine—Upper respiratory tract infection—Metformin—type 2 diabetes mellitus	0.000628	0.00997	CcSEcCtD
Epinastine—Headache—Chlorpropamide—type 2 diabetes mellitus	0.000628	0.00996	CcSEcCtD
Epinastine—Headache—Tolazamide—type 2 diabetes mellitus	0.000628	0.00996	CcSEcCtD
Epinastine—Headache—Linagliptin—type 2 diabetes mellitus	0.000622	0.00986	CcSEcCtD
Epinastine—Sinusitis—Valsartan—type 2 diabetes mellitus	0.000621	0.00985	CcSEcCtD
Epinastine—HRH2—liver—type 2 diabetes mellitus	0.000619	0.0161	CbGeAlD
Epinastine—Infection—Sitagliptin—type 2 diabetes mellitus	0.000615	0.00975	CcSEcCtD
Epinastine—Sinusitis—Orlistat—type 2 diabetes mellitus	0.000614	0.00974	CcSEcCtD
Epinastine—Rhinitis—Valsartan—type 2 diabetes mellitus	0.000596	0.00945	CcSEcCtD
Epinastine—Upper respiratory tract infection—Irbesartan—type 2 diabetes mellitus	0.000593	0.00941	CcSEcCtD
Epinastine—Pharyngitis—Valsartan—type 2 diabetes mellitus	0.00059	0.00936	CcSEcCtD
Epinastine—Pharyngitis—Orlistat—type 2 diabetes mellitus	0.000583	0.00925	CcSEcCtD
Epinastine—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000569	0.00902	CcSEcCtD
Epinastine—Upper respiratory tract infection—Losartan—type 2 diabetes mellitus	0.000558	0.00885	CcSEcCtD
Epinastine—Infection—Bromocriptine—type 2 diabetes mellitus	0.000556	0.00882	CcSEcCtD
Epinastine—Rhinitis—Metformin—type 2 diabetes mellitus	0.000543	0.00861	CcSEcCtD
Epinastine—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000537	0.00853	CcSEcCtD
Epinastine—ADRA2A—islet of Langerhans—type 2 diabetes mellitus	0.000516	0.0135	CbGeAlD
Epinastine—Rhinitis—Irbesartan—type 2 diabetes mellitus	0.000512	0.00812	CcSEcCtD
Epinastine—HTR7—cardiovascular system—type 2 diabetes mellitus	0.000509	0.0133	CbGeAlD
Epinastine—Pharyngitis—Irbesartan—type 2 diabetes mellitus	0.000507	0.00804	CcSEcCtD
Epinastine—Headache—Repaglinide—type 2 diabetes mellitus	0.000504	0.00799	CcSEcCtD
Epinastine—Sinusitis—Losartan—type 2 diabetes mellitus	0.000502	0.00797	CcSEcCtD
Epinastine—HTR7—kidney—type 2 diabetes mellitus	0.000498	0.013	CbGeAlD
Epinastine—Cough—Gliclazide—type 2 diabetes mellitus	0.000491	0.0078	CcSEcCtD
Epinastine—ADRA1A—cardiovascular system—type 2 diabetes mellitus	0.000491	0.0128	CbGeAlD
Epinastine—Rhinitis—Losartan—type 2 diabetes mellitus	0.000482	0.00765	CcSEcCtD
Epinastine—Upper respiratory tract infection—Ramipril—type 2 diabetes mellitus	0.000479	0.00759	CcSEcCtD
Epinastine—Pharyngitis—Losartan—type 2 diabetes mellitus	0.000477	0.00757	CcSEcCtD
Epinastine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000476	0.00755	CcSEcCtD
Epinastine—Pruritus—Glipizide—type 2 diabetes mellitus	0.000471	0.00746	CcSEcCtD
Epinastine—Infection—Gliclazide—type 2 diabetes mellitus	0.000457	0.00724	CcSEcCtD
Epinastine—Cough—Valsartan—type 2 diabetes mellitus	0.000451	0.00716	CcSEcCtD
Epinastine—Cough—Orlistat—type 2 diabetes mellitus	0.000446	0.00708	CcSEcCtD
Epinastine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000439	0.00697	CcSEcCtD
Epinastine—CYP2B6—nephron tubule—type 2 diabetes mellitus	0.000433	0.0113	CbGeAlD
Epinastine—ADRA1A—adipose tissue—type 2 diabetes mellitus	0.000433	0.0113	CbGeAlD
Epinastine—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000431	0.00683	CcSEcCtD
Epinastine—Infection—Valsartan—type 2 diabetes mellitus	0.000419	0.00666	CcSEcCtD
Epinastine—Headache—Glipizide—type 2 diabetes mellitus	0.000417	0.00661	CcSEcCtD
Epinastine—Infection—Orlistat—type 2 diabetes mellitus	0.000415	0.00658	CcSEcCtD
Epinastine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000399	0.00633	CcSEcCtD
Epinastine—CYP2B6—cardiovascular system—type 2 diabetes mellitus	0.000389	0.0101	CbGeAlD
Epinastine—Headache—Glimepiride—type 2 diabetes mellitus	0.000389	0.00617	CcSEcCtD
Epinastine—Cough—Irbesartan—type 2 diabetes mellitus	0.000388	0.00616	CcSEcCtD
Epinastine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000388	0.00615	CcSEcCtD
Epinastine—Infection—Metformin—type 2 diabetes mellitus	0.000382	0.00606	CcSEcCtD
Epinastine—CYP2B6—kidney—type 2 diabetes mellitus	0.000381	0.00993	CbGeAlD
Epinastine—HTR2A—retina—type 2 diabetes mellitus	0.000375	0.00978	CbGeAlD
Epinastine—Cough—Losartan—type 2 diabetes mellitus	0.000365	0.00579	CcSEcCtD
Epinastine—ADRA2A—pancreas—type 2 diabetes mellitus	0.000363	0.00946	CbGeAlD
Epinastine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000362	0.00574	CcSEcCtD
Epinastine—Infection—Irbesartan—type 2 diabetes mellitus	0.000361	0.00572	CcSEcCtD
Epinastine—ADRA2A—cortex of kidney—type 2 diabetes mellitus	0.000356	0.00927	CbGeAlD
Epinastine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000351	0.00556	CcSEcCtD
Epinastine—Infection—Losartan—type 2 diabetes mellitus	0.000339	0.00538	CcSEcCtD
Epinastine—HRH1—adipose tissue—type 2 diabetes mellitus	0.000335	0.00874	CbGeAlD
Epinastine—ADRA2A—adipose tissue—type 2 diabetes mellitus	0.000329	0.00858	CbGeAlD
Epinastine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000325	0.00516	CcSEcCtD
Epinastine—Headache—Glyburide—type 2 diabetes mellitus	0.000321	0.00509	CcSEcCtD
Epinastine—HTR2A—cardiovascular system—type 2 diabetes mellitus	0.000317	0.00828	CbGeAlD
Epinastine—HTR7—liver—type 2 diabetes mellitus	0.000315	0.00821	CbGeAlD
Epinastine—Cough—Ramipril—type 2 diabetes mellitus	0.000313	0.00497	CcSEcCtD
Epinastine—HTR2A—kidney—type 2 diabetes mellitus	0.00031	0.0081	CbGeAlD
Epinastine—ADRA1A—liver—type 2 diabetes mellitus	0.000303	0.00792	CbGeAlD
Epinastine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000299	0.00474	CcSEcCtD
Epinastine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000295	0.00468	CcSEcCtD
Epinastine—Headache—Gliclazide—type 2 diabetes mellitus	0.000288	0.00457	CcSEcCtD
Epinastine—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000287	0.0075	CbGeAlD
Epinastine—CYP3A4—kidney—type 2 diabetes mellitus	0.000287	0.0075	CbGeAlD
Epinastine—CYP2D6—kidney—type 2 diabetes mellitus	0.000283	0.00738	CbGeAlD
Epinastine—Pruritus—Metformin—type 2 diabetes mellitus	0.000272	0.00432	CcSEcCtD
Epinastine—Headache—Valsartan—type 2 diabetes mellitus	0.000265	0.0042	CcSEcCtD
Epinastine—Headache—Orlistat—type 2 diabetes mellitus	0.000261	0.00415	CcSEcCtD
Epinastine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000257	0.00407	CcSEcCtD
Epinastine—ABCB1—retina—type 2 diabetes mellitus	0.000246	0.00641	CbGeAlD
Epinastine—Pruritus—Losartan—type 2 diabetes mellitus	0.000242	0.00383	CcSEcCtD
Epinastine—Headache—Metformin—type 2 diabetes mellitus	0.000241	0.00382	CcSEcCtD
Epinastine—CYP2B6—liver—type 2 diabetes mellitus	0.000241	0.00627	CbGeAlD
Epinastine—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000231	0.00604	CbGeAlD
Epinastine—Headache—Irbesartan—type 2 diabetes mellitus	0.000227	0.00361	CcSEcCtD
Epinastine—Mirtazapine—ADRA2A—type 2 diabetes mellitus	0.000221	0.061	CrCbGaD
Epinastine—Headache—Losartan—type 2 diabetes mellitus	0.000214	0.00339	CcSEcCtD
Epinastine—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000208	0.00542	CbGeAlD
Epinastine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000207	0.00329	CcSEcCtD
Epinastine—Mirtazapine—HTR2C—type 2 diabetes mellitus	0.000203	0.0562	CrCbGaD
Epinastine—ABCB1—kidney—type 2 diabetes mellitus	0.000203	0.00531	CbGeAlD
Epinastine—ABCB1—pancreas—type 2 diabetes mellitus	0.000202	0.00527	CbGeAlD
Epinastine—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000198	0.00517	CbGeAlD
Epinastine—HTR2A—liver—type 2 diabetes mellitus	0.000196	0.00512	CbGeAlD
Epinastine—Headache—Ramipril—type 2 diabetes mellitus	0.000183	0.00291	CcSEcCtD
Epinastine—Carbamazepine—ABCC2—type 2 diabetes mellitus	0.000183	0.0506	CrCbGaD
Epinastine—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000183	0.00478	CbGeAlD
Epinastine—CYP3A4—liver—type 2 diabetes mellitus	0.000182	0.00474	CbGeAlD
Epinastine—CYP2D6—liver—type 2 diabetes mellitus	0.000179	0.00466	CbGeAlD
Epinastine—Mianserin—ADRA2A—type 2 diabetes mellitus	0.000162	0.0448	CrCbGaD
Epinastine—Mirtazapine—CYP1A2—type 2 diabetes mellitus	0.000154	0.0424	CrCbGaD
Epinastine—Mianserin—HTR2C—type 2 diabetes mellitus	0.00015	0.0413	CrCbGaD
Epinastine—Trimipramine—ADRA2A—type 2 diabetes mellitus	0.000137	0.0377	CrCbGaD
Epinastine—Nortriptyline—HTR2C—type 2 diabetes mellitus	0.000134	0.0369	CrCbGaD
Epinastine—ABCB1—liver—type 2 diabetes mellitus	0.000129	0.00335	CbGeAlD
Epinastine—Trimipramine—HTR2C—type 2 diabetes mellitus	0.000126	0.0347	CrCbGaD
Epinastine—Carbamazepine—CYP1A2—type 2 diabetes mellitus	0.000122	0.0338	CrCbGaD
Epinastine—Oxcarbazepine—CYP3A4—type 2 diabetes mellitus	0.000119	0.0328	CrCbGaD
Epinastine—Mianserin—CYP1A2—type 2 diabetes mellitus	0.000113	0.0311	CrCbGaD
Epinastine—Desipramine—HTR2C—type 2 diabetes mellitus	0.00011	0.0304	CrCbGaD
Epinastine—Nortriptyline—CYP2E1—type 2 diabetes mellitus	0.000106	0.0293	CrCbGaD
Epinastine—Oxcarbazepine—ALB—type 2 diabetes mellitus	0.000104	0.0286	CrCbGaD
Epinastine—Mirtazapine—CYP3A4—type 2 diabetes mellitus	0.000102	0.0281	CrCbGaD
Epinastine—Nortriptyline—CYP1A2—type 2 diabetes mellitus	0.000101	0.0278	CrCbGaD
Epinastine—Amitriptyline—ADRA2A—type 2 diabetes mellitus	0.000101	0.0278	CrCbGaD
Epinastine—Imipramine—HTR2C—type 2 diabetes mellitus	9.33e-05	0.0258	CrCbGaD
Epinastine—Amitriptyline—HTR2C—type 2 diabetes mellitus	9.27e-05	0.0256	CrCbGaD
Epinastine—Desipramine—CYP2E1—type 2 diabetes mellitus	8.73e-05	0.0241	CrCbGaD
Epinastine—Desipramine—CYP1A2—type 2 diabetes mellitus	8.3e-05	0.0229	CrCbGaD
Epinastine—Carbamazepine—CYP3A4—type 2 diabetes mellitus	8.11e-05	0.0224	CrCbGaD
Epinastine—Mianserin—CYP3A4—type 2 diabetes mellitus	7.47e-05	0.0206	CrCbGaD
Epinastine—Imipramine—CYP2E1—type 2 diabetes mellitus	7.4e-05	0.0204	CrCbGaD
Epinastine—Amitriptyline—CYP2E1—type 2 diabetes mellitus	7.36e-05	0.0203	CrCbGaD
Epinastine—Imipramine—CYP1A2—type 2 diabetes mellitus	7.04e-05	0.0194	CrCbGaD
Epinastine—Amitriptyline—CYP1A2—type 2 diabetes mellitus	7e-05	0.0193	CrCbGaD
Epinastine—Nortriptyline—CYP3A4—type 2 diabetes mellitus	6.68e-05	0.0184	CrCbGaD
Epinastine—Trimipramine—CYP3A4—type 2 diabetes mellitus	6.28e-05	0.0173	CrCbGaD
Epinastine—Nortriptyline—ALB—type 2 diabetes mellitus	5.82e-05	0.0161	CrCbGaD
Epinastine—Desipramine—CYP3A4—type 2 diabetes mellitus	5.5e-05	0.0152	CrCbGaD
Epinastine—Imipramine—CYP3A4—type 2 diabetes mellitus	4.66e-05	0.0129	CrCbGaD
Epinastine—Amitriptyline—CYP3A4—type 2 diabetes mellitus	4.63e-05	0.0128	CrCbGaD
Epinastine—Amitriptyline—ALB—type 2 diabetes mellitus	4.04e-05	0.0112	CrCbGaD
Epinastine—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	4.37e-06	5.17e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.36e-06	5.17e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.36e-06	5.16e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—AGT—type 2 diabetes mellitus	4.36e-06	5.16e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	4.35e-06	5.16e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.35e-06	5.15e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	4.35e-06	5.15e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.35e-06	5.15e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.34e-06	5.14e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.31e-06	5.11e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	4.3e-06	5.1e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.28e-06	5.07e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.28e-06	5.07e-05	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.28e-06	5.07e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.27e-06	5.06e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.27e-06	5.06e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—LEP—type 2 diabetes mellitus	4.27e-06	5.05e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.27e-06	5.05e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—APOE—type 2 diabetes mellitus	4.27e-06	5.05e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—AGT—type 2 diabetes mellitus	4.27e-06	5.05e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	4.26e-06	5.04e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	4.26e-06	5.04e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.24e-06	5.02e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.23e-06	5.01e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.22e-06	5e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.21e-06	4.99e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.21e-06	4.99e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	4.21e-06	4.98e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.21e-06	4.98e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.19e-06	4.97e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	4.19e-06	4.96e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—LEP—type 2 diabetes mellitus	4.18e-06	4.95e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—APOE—type 2 diabetes mellitus	4.18e-06	4.95e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—C3—type 2 diabetes mellitus	4.17e-06	4.94e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	4.13e-06	4.89e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.13e-06	4.89e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.05e-06	4.8e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PPARG—type 2 diabetes mellitus	4.05e-06	4.79e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.03e-06	4.77e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.02e-06	4.76e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	4.01e-06	4.75e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.01e-06	4.75e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.98e-06	4.71e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.97e-06	4.7e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.97e-06	4.7e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.97e-06	4.7e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—INS—type 2 diabetes mellitus	3.97e-06	4.7e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.97e-06	4.7e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.97e-06	4.7e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.97e-06	4.7e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—AGT—type 2 diabetes mellitus	3.96e-06	4.69e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.95e-06	4.67e-05	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—AKT1—type 2 diabetes mellitus	3.94e-06	4.67e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.94e-06	4.67e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	3.9e-06	4.62e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.9e-06	4.61e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.89e-06	4.61e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.89e-06	4.61e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.89e-06	4.6e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—APOE—type 2 diabetes mellitus	3.88e-06	4.6e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—LEP—type 2 diabetes mellitus	3.88e-06	4.6e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.87e-06	4.58e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.87e-06	4.58e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.87e-06	4.58e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.84e-06	4.55e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.84e-06	4.55e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	3.83e-06	4.54e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.81e-06	4.51e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.8e-06	4.5e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	3.79e-06	4.49e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.78e-06	4.48e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.78e-06	4.47e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.75e-06	4.44e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.74e-06	4.43e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.73e-06	4.42e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.73e-06	4.42e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	3.72e-06	4.4e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—SRC—type 2 diabetes mellitus	3.69e-06	4.38e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.68e-06	4.36e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.66e-06	4.34e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—INS—type 2 diabetes mellitus	3.65e-06	4.32e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.64e-06	4.31e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	3.64e-06	4.31e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—ALB—type 2 diabetes mellitus	3.64e-06	4.31e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.61e-06	4.28e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.6e-06	4.26e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.59e-06	4.26e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.59e-06	4.25e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.58e-06	4.24e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—INS—type 2 diabetes mellitus	3.57e-06	4.23e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	3.53e-06	4.19e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.53e-06	4.18e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.52e-06	4.17e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	3.52e-06	4.17e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.52e-06	4.17e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.52e-06	4.16e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.51e-06	4.16e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.51e-06	4.16e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.5e-06	4.15e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—NOS3—type 2 diabetes mellitus	3.48e-06	4.12e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PIK3R1—type 2 diabetes mellitus	3.48e-06	4.12e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.47e-06	4.11e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.47e-06	4.11e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.47e-06	4.11e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.46e-06	4.1e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.45e-06	4.09e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.45e-06	4.09e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.45e-06	4.08e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.44e-06	4.07e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	3.43e-06	4.06e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	3.41e-06	4.04e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.41e-06	4.03e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	3.39e-06	4.01e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.38e-06	4.01e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.37e-06	4e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.35e-06	3.97e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.34e-06	3.96e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—INS—type 2 diabetes mellitus	3.32e-06	3.93e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.3e-06	3.91e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.3e-06	3.91e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.28e-06	3.88e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.28e-06	3.88e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.26e-06	3.87e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	3.26e-06	3.86e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.26e-06	3.86e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	3.25e-06	3.85e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—IL6—type 2 diabetes mellitus	3.25e-06	3.85e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.24e-06	3.83e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.22e-06	3.82e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.21e-06	3.8e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.21e-06	3.8e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.21e-06	3.8e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.2e-06	3.79e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.2e-06	3.79e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.19e-06	3.78e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.19e-06	3.78e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.19e-06	3.78e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	3.19e-06	3.78e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PTGS2—type 2 diabetes mellitus	3.18e-06	3.77e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.17e-06	3.76e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.17e-06	3.76e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.14e-06	3.72e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.14e-06	3.72e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.13e-06	3.71e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.13e-06	3.71e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	3.09e-06	3.66e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.05e-06	3.61e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	3.04e-06	3.6e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	3.03e-06	3.58e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—RELA—type 2 diabetes mellitus	3.01e-06	3.56e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.01e-06	3.56e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.01e-06	3.56e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	3e-06	3.56e-05	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—AKT1—type 2 diabetes mellitus	3e-06	3.55e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.99e-06	3.54e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	2.98e-06	3.53e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.95e-06	3.49e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.91e-06	3.44e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.91e-06	3.44e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.8e-06	3.31e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.74e-06	3.25e-05	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.74e-06	3.24e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—RELA—type 2 diabetes mellitus	2.74e-06	3.24e-05	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.73e-06	3.24e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.71e-06	3.21e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.71e-06	3.21e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.7e-06	3.19e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.69e-06	3.19e-05	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.68e-06	3.18e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.66e-06	3.15e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.64e-06	3.13e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.64e-06	3.12e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.59e-06	3.07e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.59e-06	3.07e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.59e-06	3.06e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.58e-06	3.06e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.57e-06	3.04e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.56e-06	3.03e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.55e-06	3.02e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.54e-06	3.01e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.53e-06	3e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.52e-06	2.98e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.51e-06	2.97e-05	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.49e-06	2.95e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—IL6—type 2 diabetes mellitus	2.49e-06	2.95e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.49e-06	2.95e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.49e-06	2.94e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.48e-06	2.94e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.47e-06	2.93e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.47e-06	2.92e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.45e-06	2.91e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.44e-06	2.89e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.41e-06	2.85e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.41e-06	2.85e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.4e-06	2.85e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	2.37e-06	2.81e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—SRC—type 2 diabetes mellitus	2.37e-06	2.8e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.36e-06	2.8e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.36e-06	2.79e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.33e-06	2.76e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—SRC—type 2 diabetes mellitus	2.32e-06	2.74e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.31e-06	2.74e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.31e-06	2.73e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.3e-06	2.73e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.3e-06	2.73e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.3e-06	2.72e-05	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.3e-06	2.72e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	2.27e-06	2.68e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	2.27e-06	2.68e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.26e-06	2.68e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.26e-06	2.67e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.24e-06	2.66e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.21e-06	2.62e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.2e-06	2.61e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—SRC—type 2 diabetes mellitus	2.15e-06	2.55e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.13e-06	2.52e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.11e-06	2.5e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.11e-06	2.5e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.1e-06	2.48e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.09e-06	2.47e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	2.07e-06	2.46e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.07e-06	2.46e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.07e-06	2.45e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.07e-06	2.45e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.03e-06	2.4e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.02e-06	2.39e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.99e-06	2.35e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.98e-06	2.34e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.96e-06	2.32e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.92e-06	2.28e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.89e-06	2.23e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.72e-06	2.04e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.69e-06	2e-05	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—AKT1—type 2 diabetes mellitus	1.6e-06	1.89e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.59e-06	1.89e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.59e-06	1.88e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.56e-06	1.85e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.55e-06	1.83e-05	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.5e-06	1.78e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.48e-06	1.76e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.48e-06	1.76e-05	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.47e-06	1.74e-05	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.47e-06	1.74e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IL6—type 2 diabetes mellitus	1.45e-06	1.72e-05	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.44e-06	1.7e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.36e-06	1.61e-05	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.34e-06	1.58e-05	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.11e-06	1.31e-05	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	1.04e-06	1.23e-05	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	6.81e-07	8.07e-06	CbGpPWpGaD
